🔥🐔 BizChicken 🐔🔥

Companies Similar to Codexis, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Gain Therapeutics, Inc.

Gain Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Site-Directed Enzyme Enhancement Therapy platform

Gain Therapeutics, Inc. is a biotechnology company developing therapies for diseases caused by protein misfolding, focusing on rare genetic diseases and neurological disorders. It utilizes its proprietary technology to discover and develop molecules targeting misfolded proteins.

Tags: allosteric regulation, biotechnology, neurological disorders, protein misfolding, rare genetic diseases

Symbol: GANX

Recent Price: $2.18

Industry: Biotechnology

CEO: Mr. Gene Mack M.B.A.

Sector: Healthcare

Employees: 29

Address: 4800 Montgomery Lane, Bethesda, MD 20814

Phone: 301 500 1556

Last updated: 2024-12-31

Evelo Biosciences, Inc.

Evelo Biosciences, Inc. logo
Market Cap: Lowest
Employees: Low

EDP1815

Evelo Biosciences, Inc. discovers and develops oral biologics for inflammatory diseases and cancer, with key products like EDP1815 in clinical trials.

Tags: biotechnology, cancer, clinical trials, inflammatory diseases, oral biologics

Symbol: EVLO

Recent Price: $0.00

Industry: Biotechnology

CEO: Mr. Craig R. Jalbert CIRA

Sector: Healthcare

Employees: 66

Address: 620 Memorial Drive, Cambridge, MA 02139

Phone: 617 577 0300

Last updated: 2024-12-31

Kiromic BioPharma, Inc.

Kiromic BioPharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

ALEXIS-ISO-1, ALEXIS-PRO-1

Kiromic Bio Pharma, Inc. is an artificial intelligence-driven allogeneic cell therapy company that develops multi-indication T cell therapies, leveraging the Gamma Delta T cell to target solid tumors. Key products include ALEXIS-ISO-1 and ALEXIS-PRO-1.

Tags: T cell therapies, artificial intelligence, biopharmaceutical, cell therapy, oncology

Symbol: KRBP

Recent Price: $0.93

Industry: Biotechnology

CEO: Mr. Pietro Bersani CPA, J.D.

Sector: Healthcare

Employees: 35

Address: 7707 Fannin, Houston, TX 77054

Phone: 832 968 4888

Leadership

  • Pietro Bersani, CPA, Director
  • Leonardo Mirandola, PhD, Chief Scientific Officer/Interim COO
  • Scott Dahlbeck, MD, PharmD, Chief of Staff
  • Brian Hungerford, Chief Financial Officer
  • Michael Nagel, Chairperson
  • Michael Catlin, Independent Director
  • Pam Misajon, Independent Director

Last updated: 2024-12-31

Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Immuno Phage platform

Sensei Biotherapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of immunotherapies for cancer, leveraging platforms such as Immuno Phage and Tumor Microenvironment Activated Biologics.

Tags: bacteriophage, biopharmaceutical, cancer treatment, immunotherapy, monoclonal antibodies

Symbol: SNSE

Recent Price: $0.48

Industry: Biotechnology

CEO: Mr. John K. Celebi M.B.A.

Sector: Healthcare

Employees: 28

Address: 451 D Street, Rockville, MD 02210

Phone: 240 243 8000

Last updated: 2024-12-31

Telesis Bio, Inc.

Telesis Bio, Inc. logo
Market Cap: Lowest
Employees: Low

Bio Xp system

Codex DNA, Inc. is a synthetic biology company providing instruments, reagents, and services to pharmaceutical and academic laboratories. It offers the Bio Xp system, Bio Xp portal, Bio Xp kits, and other synthetic biology solutions to advance research and development.

Tags: Bio Xp system, DNA synthesis, academic laboratories, pharmaceutical, synthetic biology

Symbol: TBIO

Recent Price: $0.33

Industry: Medical - Devices

CEO: Mr. Eric Esser

Sector: Healthcare

Employees: 137

Address: 29 Hartwell Ave, Lexington, MASSACHUSETTS 92121-2993

Phone: 16179457361

Last updated: 2024-12-31

Enzo Biochem, Inc.

Enzo Biochem, Inc. logo
Market Cap: Lowest
Employees: Low

Life Sciences Products

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company specializing in the research, development, manufacture, and marketing of diagnostic and research products using genetic engineering, biotechnology, and molecular biology. It operates through segments focused on Life Sciences Products, Clinical Laboratory Services, and Therapeutics.

Tags: Biotechnology, Clinical Laboratory, Diagnostics, Genetic Engineering, Life Sciences, Molecular Biology

Symbol: ENZ

Recent Price: $0.70

Industry: Medical - Diagnostics & Research

CEO: Ms. Kara Cannon

Sector: Healthcare

Employees: 125

Address: 527 Madison Avenue, New York, NY 10022

Phone: 212 583 0100

Last updated: 2024-12-31

89bio, Inc.

89bio, Inc. logo
Market Cap: Medium
Employees: Low

pegozafermin

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.

Tags: biopharmaceutical, cardio-metabolic, clinical-stage, hypertriglyceridemia, liver diseases, nonalcoholic steatohepatitis, pegozafermin

Symbol: ETNB

Recent Price: $7.87

Industry: Biotechnology

CEO: Mr. Rohan Palekar

Sector: Healthcare

Employees: 70

Address: 142 Sansome Street, San Francisco, CA 94104

Phone: 415 432 9270

Last updated: 2024-12-31

Codexis, Inc.

Codexis, Inc. logo
Market Cap: Low
Employees: Low

Code Evolver

Codexis, Inc. discovers, develops, and sells enzymes and other proteins, offering biocatalyst products, services, and advanced protein engineering technology.

Tags: biocatalyst, biotherapeutics, enzyme technology, pharmaceutical, protein engineering

Symbol: CDXS

Recent Price: $4.67

Industry: Biotechnology

CEO: Dr. Stephen George Dilly MBBS, Ph.D.

Sector: Healthcare

Employees: 174

Address: 200 Penobscot Drive, Redwood City, CA 94063

Phone: 650 421 8100

Last updated: 2024-12-31

Coherus BioSciences, Inc.

Coherus BioSciences, Inc. logo
Market Cap: Low
Employees: Low

UDENYCA

Coherus Bio Sciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. It markets UDENYCA and develops various biosimilar and immuno-oncology products.

Tags: Toripalimab, UDENYCA, biopharmaceutical, biosimilars, immuno-oncology

Symbol: CHRS

Recent Price: $1.50

Industry: Biotechnology

CEO: Mr. Dennis M. Lanfear

Sector: Healthcare

Employees: 306

Address: 333 Twin Dolphin Drive, Redwood City, CA 94065

Phone: 650 649 3530

Last updated: 2024-12-31

Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. logo
Market Cap: High
Employees: Low

therapeutic monoclonal and bispecific antibodies

Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies for treating inflammatory diseases and cancers.

Tags: biopharmaceutical, bispecific antibodies, cancer treatment, inflammatory diseases, monoclonal antibodies

Symbol: CLDX

Recent Price: $25.12

Industry: Biotechnology

CEO: Mr. Anthony S. Marucci M.B.A.

Sector: Healthcare

Employees: 160

Address: Perryville III Building, Hampton, NJ 08827

Phone: 908 200 7500

Leadership

  • Anthony S. Marucci, Founder, President, Chief Executive Officer and Director
  • Tibor Keler, Ph.D., Founder, Executive Vice President and Chief Scientific Officer
  • Diane C. Young, M.D., Senior Vice President and Chief Medical Officer
  • Elizabeth Crowley, Senior Vice President, Chief Product Development Officer
  • Sam Martin, Senior Vice President and Chief Financial Officer
  • Ronald A. Pepin, Ph.D., Senior Vice President and Chief Business Officer
  • Richard Wright, Ph.D., Senior Vice President and Chief Commercial Officer
  • Sarah Cavanaugh, Senior Vice President, Corporate Affairs and Administration
  • Margo Heath-Chiozzi, M.D., Senior Vice President, Regulatory Affairs
  • Freddy A. Jimenez, Esq., Senior Vice President and General Counsel
  • Karen L. Shoos, J.D., Former Chair, Director of Operations, Maryland Tech Council Venture Mentoring Services Program
  • Keith L. Brownlie, Former Partner, Ernst & Young LLP
  • Herbert J. Conrad, Former President, Roche Pharmaceuticals US
  • James J. Marino, J.D., Former Partner, Dechert LLP
  • Harry H. Penner, Jr., J.D., L.L.M., Former Chairman and CEO, Nascent Bioscience
  • Cheryl L. Cohen, President, CLC Consulting; Former Chief Commercial Officer of Medivation, Inc.
  • Dr. Garry Neil, Chief Executive Officer; Chair of the Board, Avalo Therapeutics
  • Rita Jain, M.D., Former Executive Vice President, Chief Medical Officer of ChemoCentryx, Inc.
  • Carl June, M.D.,
  • Michel Nussenzweig, M.D., Ph.D.,
  • Marc E. Rothenberg M.D., Ph.D.,
  • Joseph Schlessinger, Ph.D.,
  • Louis Weiner, M.D.,

Last updated: 2024-12-31

Curis, Inc.

Curis, Inc. logo
Market Cap: Lowest
Employees: Lowest

Emavusertib

Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.

Tags: biotechnology, cancer treatment, clinical trials, drug development, oncology

Symbol: CRIS

Recent Price: $3.14

Industry: Biotechnology

CEO: Mr. James E. Dentzer

Sector: Healthcare

Employees: 49

Address: Building C, Lexington, MA 02421

Phone: 617 503 6500

Leadership

  • Martyn D. Greenacre, Chair of the Board
  • John Hohneker, M.D., Director
  • Kenneth I. Kaitin, Ph.D., Director
  • Anne E. Borgman, M.D., Director
  • Marc Rubin, M.D., Director
  • James Dentzer, Chief Executive Officer and Director

Last updated: 2024-12-31

Dyadic International, Inc.

Dyadic International, Inc. logo
Market Cap: Lowest
Employees: Lowest

C1 platform

Dyadic International, Inc. is a biotechnology platform company that develops, produces, and sells enzymes and other proteins, focusing on the development and manufacturing of vaccines and drugs using its proprietary C1 platform.

Tags: C1 platform, biotechnology, drug development, enzymes, proteins, vaccines

Symbol: DYAI

Recent Price: $1.78

Industry: Biotechnology

CEO: Mr. Mark A. Emalfarb

Sector: Healthcare

Employees: 7

Address: 140 Intracoastal Pointe Drive, Jupiter, FL 33477-5094

Phone: 561 743 8333

Leadership

  • Patrick Lucy, Chairman of the Board, President and Chief Executive Officer
  • Mark A. Emalfarb, Founder, Chief Executive Officer
  • Seth J. Herbst, MD, Chairman of the Nominating Committee
  • Jack L. Kaye, Chairman of the Audit Committee
  • Arindam Bose, Chairman of the Science and Technology Committee
  • Michael P. Tarnok, Chairman of the Board

Last updated: 2024-12-31

Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ELX-02

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing ribosome modulation therapies for rare and ultra-rare premature stop codon diseases. The company's lead investigational drug, ELX-02, is in Phase 2 clinical trials for cystic fibrosis and nephropathic cystinosis.

Tags: ELX-02, biopharmaceutical, clinical trials, cystic fibrosis, nephropathic cystinosis, rare diseases, ribosome modulation

Symbol: ELOX

Recent Price: $0.00

Industry: Biotechnology

CEO: Mr. Sumit Aggarwal M.B.A.

Sector: Healthcare

Employees: 18

Address: 480 Arsenal Way, Watertown, MA 02472

Phone: 781 577 5300

Last updated: 2024-12-31

Omega Therapeutics, Inc.

Omega Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

OMEGA Epigenomic Programming platform

Omega Therapeutics, Inc. is a development-stage biopharmaceutical company leveraging its OMEGA Epigenomic Programming platform to utilize the power of epigenetics for therapeutic interventions across various diseases.

Tags: biopharmaceutical, chronic liver diseases, corneal regeneration, epigenetics, gene control, idiopathic pulmonary fibrosis

Symbol: OMGA

Recent Price: $0.80

Industry: Biotechnology

CEO: Mr. Mahesh Karande

Sector: Healthcare

Employees: 93

Address: 20 Acorn Park Drive, Cambridge, MA 02140

Phone: 617 949 4360

Leadership

  • Mahesh Karande, President & Chief Executive Officer
  • Kaan Certel, Ph.D., Chief Business Officer
  • Jennifer Nelson, Ph.D., Senior Vice President, Research
  • Tony Mullin, Chief People Officer
  • Barbara Chan, Senior Vice President, Finance and Chief Accounting Officer
  • Lisamarie Fahy, Senior Vice President, Clinical Development Operations
  • Joe Newman, Ph.D., Senior Vice President, Early Discovery
  • Jeff Atkinson, Ph.D., Vice President, Technical Operations
  • Eva Stroynowski, Senior Vice President, Investor Relations and Corporate Affairs

Last updated: 2024-12-31

Scopus BioPharma Inc.

Scopus BioPharma Inc. logo
Market Cap: Lowest
Employees: Lowest

Duet Platform

Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.

Tags: biopharmaceutical, cancer treatment, gene therapy, immuno-oncology, therapeutics

Symbol: SCPS

Recent Price: $0.00

Industry: Biotechnology

CEO: Dr. Alan D. Horsager Ph.D.

Sector: Healthcare

Employees: 13

Address: 420 Lexington Avenue, New York, NY 10170

Phone: 212 479 2513

Last updated: 2024-12-31

Seer, Inc.

Seer, Inc. logo
Market Cap: Low
Employees: Low

Proteograph Product Suite

Seer, Inc. is a life sciences company focused on developing and commercializing products to decode the secrets of the proteome. It offers the Proteograph Product Suite, enabling proteomic research for therapeutic and diagnostic studies.

Tags: Proteograph, biotechnology, life sciences, proteome, proteomics, research

Symbol: SEER

Recent Price: $2.27

Industry: Biotechnology

CEO: Dr. Omid C. Farokhzad M.D., Ph.D.

Sector: Healthcare

Employees: 147

Address: 3800 Bridge Parkway, Redwood City, CA 94065

Phone: 650 453 0000

Last updated: 2024-12-31

10x Genomics, Inc.

10x Genomics, Inc. logo
Market Cap: High
Employees: Medium

chromium instruments

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems globally. Their products include chromium instruments and single cell solutions for gene expression and immune profiling.

Tags: biological systems, chromium instruments, epigenetics, gene expression, immune profiling, life science, technology

Symbol: TXG

Recent Price: $14.35

Industry: Medical - Healthcare Information Services

CEO: Dr. Serge Saxonov Ph.D.

Sector: Healthcare

Employees: 1259

Address: 6230 Stoneridge Mall Road, Pleasanton, CA 94588-3260

Phone: 925 401 7300

Last updated: 2024-12-31

PDF Solutions, Inc.

PDF Solutions, Inc. logo
Market Cap: Medium
Employees: Medium

Exensio

PDF Solutions, Inc. offers proprietary software and physical intellectual property products focused on integrated circuit designs, measurement hardware, and methodologies to improve yield and performance in semiconductor manufacturing.

Tags: assembly operations, integrated circuits, manufacturing analytics, process control, software, test operations

Symbol: PDFS

Recent Price: $27.50

Industry: Software - Application

CEO: Dr. John K. Kibarian Ph.D.

Sector: Technology

Employees: 493

Address: 2858 De La Cruz Boulevard, Santa Clara, CA 95050

Phone: 408 280 7900

Leadership

  • Andrzej Strojwas, Ph.D., Chief Technology Officer
  • John K. Kibarian, Ph.D., President, Chief Executive Officer, Director, and Co-Founder
  • Adnan Raza, Executive VP, Finance and Chief Financial Officer
  • Kimon Michaels, Ph.D., Executive VP, Products and Solutions, Director, and Co-Founder
  • Joseph R. Bronson, Director
  • Dr. Chi-Foon Chan, Director
  • Nancy Erba, Chief Financial Officer
  • Michael B. Gustafson, Executive Chairman and Independent Board Director
  • Dr. John K. Kibarian, President and Chief Executive Officer
  • Ye Jane Li, Strategic Advisor
  • Dr. Kimon Michaels, Vice President, Design for Manufacturability
  • Shuo Zhang, Board Member

Last updated: 2024-12-31

Exelixis, Inc.

Exelixis, Inc. logo
Market Cap: Highest
Employees: Medium

CABOMETYX, COMETRIQ, COTELLIC, MINNEBRO

Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes new medicines to treat cancers, primarily in the United States. Its products include CABOMETYX, COMETRIQ, COTELLIC, and MINNEBRO.

Tags: biotechnology, cancer treatment, oncology, pharmaceuticals

Symbol: EXEL

Recent Price: $33.70

Industry: Biotechnology

CEO: Dr. Michael M. Morrissey Ph.D.

Sector: Healthcare

Employees: 1310

Address: 1851 Harbor Bay Parkway, Alameda, CA 94502

Phone: 650 837 7000

Last updated: 2024-12-31

Twist Bioscience Corporation

Twist Bioscience Corporation logo
Market Cap: High
Employees: Medium

synthetic DNA-based products

Twist Bioscience Corporation is a synthetic biology company that manufactures and sells synthetic DNA-based products. The company's platform enables the creation of synthetic DNA using a silicon chip and offers products including synthetic genes, sample preparation tools, and antibody libraries for drug discovery.

Tags: DNA synthesis, biotechnology, data storage, drug discovery, synthetic DNA, synthetic biology

Symbol: TWST

Recent Price: $47.23

Industry: Medical - Diagnostics & Research

CEO: Dr. Emily Marine Leproust Ph.D.

Sector: Healthcare

Employees: 919

Address: 681 Gateway Boulevard, South San Francisco, CA 94080

Phone: 800 719 0671

Last updated: 2024-12-31